Liminal BioSciences
Pre-clinicalWe are a development-stage biopharmaceutical company focused on developing distinctive novel small molecule therapeutics for metabolic, fibrotic and inflammatory diseases using our drug discovery platform and data-driven approach.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $35M
About
We are a development-stage biopharmaceutical company focused on developing distinctive novel small molecule therapeutics for metabolic, fibrotic and inflammatory diseases using our drug discovery platform and data-driven approach.
Small Molecules
Funding History
2Total raised:$35M
Series B$25MNov 15, 2022
Series A$10MJun 15, 2021